logo conference-reports

Conference Reports

Educational funding by logo MSD Oncology

ESMO 2019 — Bladder cancer: immunotherapy on top of chemotherapy brings first improvement in decades

Largest trial ever on urothelial cancer sees higher response rates with the addition of atezolizumab.